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Abstract
Background: Weight management in pregnancy guidelines exist, although dissemination alone is an ineffective
means of implementation. Midwives identify the need for support to overcome complex barriers to practice. An
evaluation of an intervention to support midwives’ guideline implementation would require a large-scale cluster
randomised controlled trial. A pilot study is necessary to explore the feasibility of delivery and evaluation prior to a
definitive trial. The GestationaL Obesity Weight management: Implementation of National Guidelines (GLOWING)
trial aims to test whether it is feasible and acceptable to deliver a behaviour change intervention to support midwives’
implementation of weight management guidelines.
Methods: GLOWING is a multi-centre parallel group pilot cluster randomised controlled trial comparing the delivery of
a behaviour change intervention for midwives versus usual practice. Four NHS Trusts (clusters) will be randomised to
intervention and control arms, stratified by size of maternity services. The intervention uses social cognitive theory and
consists of face-to-face midwifery training plus information resources for routine practice. The main outcomes are
whether the intervention and trial procedures are feasible and acceptable to participants and the feasibility of recruitment
and data collection for a definitive trial. Target recruitment involves all eligible midwives in the intervention arm recruited
to receive the intervention, 30 midwives and pregnant women per arm for baseline and outcome questionnaire
data collection and 20 midwives and women to provide qualitative data. All quantitative and qualitative analyses
will be descriptive with the purpose of informing the development of the definitive trial.
(Continued on next page)
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Discussion: This pilot study has been developed to support community midwives’ implementation of guidelines.
Community midwives have been selected as they usually carry out the booking appointment which includes measuring
and discussing maternal body mass index. A cluster design is the gold standard in implementation research as there
would be a high risk of contamination if randomisation was at individual midwife level: community midwives usually
work in locality-based teams, interact on a daily basis, and share care of pregnant women. The results of the pilot trial will
be used to further develop and refine GLOWING prior to a definitive trial to evaluate effectiveness and cost-effectiveness.
Trial registration: ISRCTN46869894; retrospectively registered 25th May 2016.
Keywords: Cluster RCT, Implementation, Guidelines, Midwives, Behaviour change, Social cognitive theory, Obesity, Weight
management, Pregnancy
Background
First trimester maternal obesity (body mass index
(BMI) ≥ 30 kg/m2) in England doubled from 7.6% in
1989 (approximately 45,000 women) to 15.6% in 2007
(approximately 92,500 women) [1], and data from
2015 suggests 1 in 5 women in the UK enter pregnancy
with an obese BMI [2]. Maternal obesity is significantly
associated with inequalities including socio-economic
deprivation, ethnic minority groups, and unemployment
[1, 3]. Maternal obesity has short- and long-term implica-
tions for women and babies, including maternal and neo-
natal mortality, gestational diabetes, thromboembolism,
infection, haemorrhage, reduced breast feeding, congenital
anomalies, and obesity development in offspring [4–9].
However, pregnancy is also an opportunity for interven-
tion to address womens personal behaviour change for
obesity for a number of reasons. Pregnancy is a period of
metabolic plasticity; there is also a shift in attitude and
spontaneous change in behaviour, making women more
receptive to nutrition advice, and interventions have the
potential to prevent childhood obesity among future gen-
erations [10, 11]. The National Institute for Health and
Care Excellence (NICE) identifies pregnancy as being a
public health opportunity for health professionals to ad-
vise and support women due to women’s increased motiv-
ation and as pregnancy is a vulnerable life stage for
increased risk of excessive weight gain, weight retention
and long-term obesity development [12, 13].
Maternal obesity and weight management recommen-
dations are included in the UK and international guide-
lines [14, 15]. NICE evidence-based guidelines for weight
management before, during and after pregnancy include
recommendations for health professional advice and sup-
port including discussing obesity risks and weight-related
behaviour, incorporating practical and tailored advice and
being sensitive to women’s weight concerns [16]. These
public health guidelines specific to weight management in
pregnancy are now in the public domain and therefore
available to health professionals. However, passive dissem-
ination of guidelines alone is an ineffective means of
implementing them into clinical practice and is therefore
likely to reduce the chance of positive health outcomes for
patients compared with more active strategies [17, 18].
Midwives have an increasing public health role and are
expected to implement national guidelines into routine
antenatal care. However, they also report a lack of confi-
dence in their weight management expertise and face
difficulties in discussing obesity due to its sensitive
nature [19], resulting in inconsistent and ad hoc advice
and variation in the level of support provided to pregnant
women [1, 11, 20, 21]. Patients (including non-pregnant
populations) and pregnant women with obesity have
described health professionals’ (including midwives)
communication as ambivalent, insulting, judgemental,
insensitive and patronising [22–25]. Negative experiences
have led to women avoiding or delaying accessing health-
care [11, 20] and avoiding confrontation about humiliat-
ing treatment due to fear of jeopardising maternity care
[26]. Pregnant women also report that they receive inad-
equate information about nutrition and physical activity
from health professionals and are often left confused by
conflicting information [27, 28]. A systematic review has
been carried out to identify published or ongoing inter-
ventions which aim to support health professionals with
their maternal obesity and weight management practice.
No papers meeting the eligibility criteria were identified,
highlighting the importance of further research [29].
A recent report by the World Health Organisation
European Office identified that health professional cap-
acity building is required to improve maternal nutrition
and offspring health [30]. They reported that health pro-
fessionals needed to be trained pre- and in-service, using
the latest evidence-based guidelines on nutrition, diet
and physical activity, including how to develop and put
into practice skills such as counselling and commu-
nication approaches to reduce stigma [30]. In the UK,
guidelines published by NICE and the Royal College of
Obstetricians and Gynaecologists have identified pro-
fessional development as a priority area in relation to
maternal obesity, recommending that health profes-
sionals should have knowledge and skills to advise on
weight management and behaviour change, sensitive
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communication techniques and knowledge of local ser-
vices [16, 31]. Midwives have also expressed the need for
training and skills development to support them to over-
come barriers to practice, comparing obesity with other
complex sensitive topics for which structured training is
available (e.g. domestic violence) [11, 19, 20]. While
recognising the remit of their public health role, mid-
wives identify a key barrier to addressing obesity and
weight management in pregnancy to be a lack of know-
ledge, skills and confidence to do this effectively, leading
to variation in the advice and support offered between
midwives and maternity units [1, 21].
A future evaluation of an intervention to support
health professional capacity for guideline implementa-
tion would answer the following research questions: (1)
does a theory-based intervention facilitate the imple-
mentation of weight management guidelines into mid-
wifery practice and (2) does midwifery implementation
of weight management guidelines mediate obese preg-
nant and postnatal women’s weight and weight-related
behaviours? The primary and secondary outcomes would
be measures (and determinants) of midwifery practice
and measures of women’s weight status and weight-
related behaviours. Such an evaluation would require a
large-scale cluster randomised controlled trial (RCT)
where the quality of the trial can be affected by poor
recruitment and retention rates; limited acceptability of,
or compliance with, the intervention; and process issues
in the delivery both of the intervention and of trial pro-
cedures [32]. The Medical Research Council stresses the
importance of conducting pilot studies prior to large-
scale trials when the intervention has multiple compo-
nents [32] to reduce uncertainty and optimise the
chances of a successful summative evaluation. Pilot stu-
dies can explore such potential issues to inform the
design and conduct of a definitive study [33, 34]. There-
fore, a necessary prerequisite, and the focus of this study,
is piloting to ensure methodological rigour and scientific
validity and inform the development of a protocol for a
definitive trial [33]. A rehearsal (external) pilot trial of the
intervention will be carried out, with integrated process
evaluation. A key priority for assessment of complex inter-
ventions includes identifying how it works in everyday
practice [32], which will be achieved through the process
evaluation element of the rehearsal pilot trial.
Methods
The GLOWING pilot trial is registered with the
International Standard Randomised Controlled Trials
Number (ISRCTN) 46869894 (Additional file 1). This
protocol describes the GLOWING pilot cluster RCT
using the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist (Additional file 2).
Aim
The GestationaL Obesity Weight management:
Implementation of National Guidelines (GLOWING)
pilot study aims to test whether it is feasible and
acceptable to deliver a theory-based behaviour change
intervention to support midwives in overcoming barriers
to practice and to facilitate the implementation of weight
management guidelines. The specific pilot study objectives
are to:
1. Pilot the intervention delivery, data collection
and analysis methods to assess feasibility and
acceptability thereof
2. Explore the intervention’s active ingredients
(in success or failure) through process evaluation
3. Collect baseline and outcome data required to
inform sample size estimations and scope data
collection procedures for economic evaluation
within the definitive trial
Aim Design and setting
GLOWING is a multi-centre parallel group cluster
RCT comparing the delivery of a theory-based behaviour
change intervention for community midwives versus usual
practice. Usual practice is the most relevant comparator
and equivalent to ‘standard care’ in patient-facing studies.
The clusters are four NHS Trusts which provide maternity
care in the North East of England, UK (see Fig. 1).
Intervention
The intervention development followed a four-step
approach for developing theory-informed interventions
designed to facilitate the development of interventions to
change clinical practice [35]. The four steps comprised:
(1) identification of what needs to be changed and by
whom; (2) identification of barriers and enablers ad-
dressed by the intervention using a theoretical framework;
(3) identification of intervention components and modes
of delivery that would help overcome barriers and
enhance enablers; and (4) determining how the behaviour
change can be measured and understood. Key barriers to
guideline implementation best fit with the social cognitive
theory (SCT), and this is the behaviour change theory
used to develop the GLOWING intervention. SCT is
based on the principles that the person, environment, and
behaviour all interact and influence one another and that
behaviours are directly related to an individual’s behav-
ioural goals [36]. The theoretical construct at the core of
the personal factors in the SCT is midwives’ self-efficacy;
additional constructs include outcome expectancies and
goals. The GLOWING intervention content, materials
and outcome measures were developed using a systematic
approach and best-available evidence. Sources included
methods of behaviour change aligned to SCT [37], a
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systematic review of barriers and facilitators to practice
which had synthesised evidence on health professionals
perspective of appropriate ‘training’ modes of delivery and
behaviour change techniques [19], evidence from nine
related EPOC Cochrane reviews on intervention methods
to change health professional behaviours [38–46] and
existing behaviour change technique taxonomies [47, 48].
The details of the intervention are reported using the
template for intervention description and replication
(TIDieR) checklist and guide [49] (see Additional file 3).
The GLOWING intervention consists of a one-off full
day of intensive face-to-face training for small groups of
eligible midwives (n = 6 per session), plus the provision
of training resources for their continued professional de-
velopment and information resources for midwives to
share with pregnant women during routine antenatal
contacts. The face-to-face intervention sessions will be
delivered by a research midwife in either the local NHS
Hospital Trust education facility or in a community set-
ting with appropriate facilities for group-based learning
(such as computer, projector, seating and tables). The
intervention is divided into five sessions: introduction,
weight communication, weight management, consolida-
tion of the day, and summary and evaluation. The ses-
sions include a combination of didactic and interactive
activities (lectures, watching a video of a midwife book-
ing appointment, individual and group reflection, group
discussions, scripted role plays, action planning and
coping planning) and will be delivered as graded tasks
throughout the intervention delivery (1-day training).
Graded tasks start with small tasks to gain confidence,
with each subsequent task building on the previous one.
The midwives attending the GLOWING sessions will be
provided with a training pack including all of the inter-
vention materials (e.g. lecture slides, reflection activities),
plus additional resources to support their practice such
as the NICE guidelines and relevant British Dietetic
Association ‘Food Factsheets’. The intervention arm clusters
will also be provided with a 1 year supply of written
resource packs for midwives to share with pregnant and
postnatal women with a booking BMI ≥ 30.0 kg/m2. These
packs include a combination of existing nationally available
patient-facing resources on maternal obesity and weight
management (e.g. booklets produced by Tommy’s the Baby
Charity, Start4Life, First Steps Nutrition Trust) and
resources developed specifically for GLOWING, including
leaflets detailing reliable national evidence-based informa-
tion sources (e.g. NHS Choices, First Steps Nutrition Trust,
British Dietetic Association, the EatWell Guide) and details
of local support available to women in the pilot site areas
(e.g. local exercise classes for pregnant or postnatal women,
local websites with further information on support services).
The intervention has been developed to be delivered
consistently for each GLOWING session, and the facilitator
will have a pack and script to use during the intervention
delivery with the aim of standardising the content and deliv-
ery of each intervention session with midwives. However,
the interactive nature of the intervention will require
the facilitator to be responsive to the midwives’ discus-
sions and questions on the day which makes it difficult
to estimate some of the timings required for each train-
ing component. Therefore, the first GLOWING session
will be used to pilot the timing of the intervention de-
livery, and the intervention timings will be adapted if ne-
cessary for the remaining sessions.
Participants, inclusion and exclusion criteria
The intervention and control midwifery participants are
community midwives within the trusts (clusters) as the
guidelines are most relevant to this population of health
professionals who have the predominant public health role
in pregnancy. Hospital-based midwives with a specific
Fig. 1 Overview of cluster trial design
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obesity or weight management role will also be included.
Hospital-based midwives without a specific maternal obesity
or weight management role and non-midwifery health
professionals will be excluded.
The intervention does not target pregnant women
directly. However, if the intervention is effective and
midwives implement guidelines into routine practice,
then this would result in evidence-based provision of
information, advice and support to help pregnant
women achieve nutritionally healthy diet and physical
activity behaviours. Pregnant and postnatal women with
pre-pregnancy obesity will be included as participants
only for the purposes of piloting outcome data col-
lection and to provide data for the process evaluation.
Pregnant women will be included if they have a
booking BMI ≥ 30 kg/m2 (proxy measure for pre-
pregnancy BMI), are ≥ 18 years of age (teenage preg-
nancies require specific nutritional support), have a
singleton pregnancy (multiple pregnancies require specific
nutritional support) and if they have had their 12-week
ultrasound scan and their pregnancy has progressed beyond
the high-risk period for miscarriage. Pregnant women will
be excluded if they have a medical condition other than
obesity which requires them to receive specialist weight
management advice for that condition (e.g. women with
pre-gestational diabetes who are attending a specialist ante-
natal diabetes clinic, pregnant women who have had bariat-
ric surgery and require specialist nutritional support) and
those with substance misuse or known cause for concern
(e.g. domestic violence).
Inability to speak or read English is an exclusion
criterion for both midwives and pregnant women as data
will be collected by questionnaires which lack validation
in non-English language.
Sample size and randomisation
Sample sizes for pilot studies are typically not informed
by formal power calculations, but rather by pragmatism
and resource constraints; it has been proposed that out-
come data from approximately 30 participants per arm
is adequate [33]. Four clusters will be recruited with two
per trial arm. The aim is to have outcome data from 30
midwives and 30 pregnant women per trial arm, and to
allow for dropout, we will recruit 18 midwives and
pregnant women per trust.
Computer randomisation of trusts to intervention or
control arms will be performed by a statistician (DH)
using anonymised unique IDs to prevent allocation bias.
Randomisation will be stratified by size of the maternity
service within the NHS Trust (large and small trusts will
be categorised based on the number of bookings/year).
Computer randomisation of unique ID codes will also be
carried out within each cluster to select midwives and
pregnant women to provide baseline, outcome and
process evaluation data. We aim to recruit seven mid-
wives and women in each trust for qualitative interviews
and focus groups, with the aim of obtaining data from
10 midwives and women per trial arm. The random
sampling and recruitment procedures will continue until
the target sample sizes are reached. Random sampling
has been chosen for the qualitative research as an
attempt to avoid engaging with only those midwives with
a specific interest in the topic, as the process evaluation
requires the exploration of positive and negative perspec-
tives. Baseline data collection (midwives and pregnant
women) will be carried out before cluster randomisation
(i.e. allocation concealment prior to consent and baseline
data collection). Written informed consent will be obtained
from midwives and pregnant women prior to their involve-
ment in any study-specific procedures.
Due to the nature of the intervention, it is not possible
for the intervention delivery team or midwives to be
blinded. However, some degree of blinding will be utilised
when possible, including the use of unique ID codes to
blind the statistician to the clusters and midwife and preg-
nant women participant details during randomisation; the
pregnant women will not be informed by the researchers
whether their midwives are in the intervention or control
arm of the study, and midwives will be asked not to dis-
close this information to women during their consulta-
tions. Midwives will not be aware which arm of the trial
their NHS Trust has been allocated to when consenting
and providing baseline data.
Recruitment
The four NHS Trusts (clusters) which have agreed to
participate in the GLOWING pilot trial agreed not to
deliver any structured training on maternal obesity or
weight management during the trial period, over and
above their usual mandatory training for routine clinical
care (e.g. it was permissible to include usual mandatory
training on the local clinical care requirements relating
to obesity such as BMI criteria for gestational diabetes
screening). Eligible midwives within the clusters will be
identified by the research midwife teams within the NHS
Trust clusters who will screen staff lists and assign a
unique ID to all potential midwife participants. There
will be three stages of recruitment and consent for
midwives: (1) we aim to recruit and consent all eligible
midwives in the intervention clusters to participate in
the intervention sessions (intervention arm only); (2) a
random subset of midwives who participate in the
intervention sessions will be selected and approached
to participate in focus groups as part of the process
evaluation (intervention arm only); and (3) a random
sample of all eligible midwives in each cluster will be
invited to provide baseline and follow-up questionnaire
data (control and intervention arms).
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Screening for eligible pregnant women will be carried
out by the research midwife teams in each cluster using the
antenatal booking data recorded in the electronic patient
records, and all such potential pregnant women will be
assigned a unique ID. A random sample of pregnant
women in each cluster will be selected to be approached at
their 20-week scan appointment for recruitment and
consent to provide questionnaire data at baseline (before
the intervention delivery). A random sample of different
pregnant women will be selected to be approached for
recruitment and consent to provide questionnaire data fol-
lowing the intervention delivery and at subsequent data
collection time points up to 1 year postnatal. A different
population of pregnant women is required as the women
who provide data pre-intervention will have delivered by
the time we are ready to collect post-intervention data.
The purpose of baseline data collection is to explore clus-
tering of behaviours at baseline rather than to explore
change in women’s behaviours pre- and post-intervention.
A random subset of post-intervention pregnant women
from each cluster will be asked to provide qualitative
process evaluation data. Due to the potential burden of data
collection without any direct benefit of participation in the
study, women will receive a £10 high street gift voucher for
every data collection episode at baseline and follow-up.
Recruitment and consent of midwives and pregnant
women will be carried out by the researchers identified
in the delegation log at each cluster, primarily the re-
search midwife teams or the chief investigator (NH),
who have Good Clinical Practice certificates and have
received training in informed consent. All potential
midwives and pregnant women approached for recruit-
ment will receive an information sheet and have the
opportunity to discuss the research before deciding
whether to consent to participate (see Additional file 4
for information sheets and consent forms).
Participant withdrawal
Should any midwives or pregnant women decide to
withdraw from the study, efforts will be made to report
the reason for withdrawal. Midwife withdrawal could
occur at any phase of involvement including participat-
ing in the intervention sessions, questionnaire comple-
tion or focus group participation. If any midwives
withdraw part-way through the intervention training
sessions (e.g. due to family emergency) or if they do not
turn up (e.g. due to illness), then they will be offered the
opportunity to attend another session to complete their
training. If a midwife requests to withdraw from ques-
tionnaire or focus group data collection then the follow-
ing actions will be taken: (1) for requests to completely
withdraw from the study, no further data will be col-
lected, but we will retain data already provided and used
in the analysis; (2) for requests to withdraw due to
change in circumstances (e.g. retirement rather than not
wanting to participate further), we will retain data
already provided and attempt to collect exit data (final
outcome data) at the point of withdrawal and any data
provided will be used in the analysis; and (3) for non-
explicit withdrawal (e.g. non-return of questionnaire), up
to three repeat attempts will be made to collect this
data. The withdrawal of pregnant or postnatal women
could be due to the researcher’s or women’s decision.
Adverse pregnancy events (unrelated to the interven-
tion) that would result in automatic withdrawal would
be the death of the woman or baby (including miscar-
riage, late fetal loss, stillbirth, neonatal death and infant
death up to 1 year postnatal follow-up) to avoid causing
unneccessary distress to women or their families. For ex-
plicit or non-explicit withdrawal from data collection,
the same actions will be taken as for midwives.
Measures
The main outcomes of the pilot study relate to
whether the intervention and trial procedures are
feasible and acceptable to midwives and pregnant
women, to assess the feasibility of collecting the out-
come measures required for a definitive trial and to
prioritise which outcomes should be primary or sec-
ondary outcomes for a definitive trial. An overview
of the planned participant timeline is presented in
the SPIRIT flow diagram (Table 1).
The primary outcome measures for the pilot trial are:
1. Recruitment rate of midwives attending the
intervention training day in the intervention
arm, calculated as a percentage of all eligible
midwives invited to attend the GLOWING
intervention (training) session
2. Feasibility of intervention delivery, calculated as
the number of intervention sessions delivered
with the planned number of midwives (six/
session) in attendance at each session
3. Intensity of intervention delivery, calculated as the
number of intervention sessions required to deliver
the intervention to all recruited midwives in the
intervention arm at the end of intervention delivery
4. Time required for intervention delivery, calculated
for both intervention sites as the number of weeks
from the first contact with the site to arrange the
delivery of the intervention, and the delivery of the
final intervention session
5. Fidelity of intervention delivery, calculated as the
frequency of the delivery of the intervention as
planned measured by direct observation and video
recording of the intervention sessions, and frequency
of deviation from protocol
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The secondary outcome measures are:
1. Process evaluation of the content resources, and
delivery of the intervention, to be measured by:
(a)Direct observations and video recordings
of the intervention delivery for all
intervention sessions
(b)Evaluation forms to be completed by midwives
attending the intervention, on the day of
the intervention
(c)Focus groups with a sample of midwives who
have received the intervention, 1 month after
intervention delivery
2. Process evaluation of the implementation of guidelines
into routine midwifery practice following the
intervention, to be measured by:
(a)Midwife questionnaires at baseline (pre-intervention)
and 3 and 6 months after intervention delivery,
including characteristics (number of years practice,
speciality, ethnic group, age and gender),
self-reported routine practice specific to the
NICE guideline recommendations, SCT constructs
of the guideline behaviours (self-efficacy, outcome
expectancies, goals/intentions), knowledge of the
guideline recommendations, Beliefs About Obese
People (BAOP) scale [50], vignettes of different
scenarios they might encounter in routine practice
(simulated practice)
(b)Focus groups with a sample of midwives who
have received the intervention, 1 month after
intervention delivery
3. Women’s experience of midwifery care relating to
their weight and implementation of midwifery
advice and support into their own behaviours,
among women with obesity (BMI ≥ 30 kg/m2)
receiving care from midwives, to be measured by:
(a)Questionnaires at baseline pre-intervention and
at follow-up post-intervention: women’s
socio-demographic information (including
maternal age, gestation, BMI, ethnic group,
parity, employment status, qualifications, postcode),
self-report of their midwives’ practice specific to
the guideline recommendations (developed to
reflect the midwives’ self-reported routine practice
behaviour measurements), food frequency
questionnaire (validated in pregnancy) [51],
pregnancy physical activity questionnaire
(validated in pregnancy) [52], psychosocial
measures for understanding weight-related
behaviours in pregnant women questionnaire
(validated in pregnancy) [53], therapeutic alliance
with midwives using the Health Care Alliance
Questionnaire (validated in pregnancy) [54] and
quality of life (EQ5D 5L)
(b)Weight measurements in the third trimester and
at 3, 6, 9 and 12 months postnatal
(c)Semi-structured interviews in the third trimester
and at 6 months postnatal
4. Data required for sample size estimations for a
future definitive trial will be measured by:
(a)Calculating variance of the intervention
primary and secondary outcome measures
(data collection by questionnaires)
for the midwives at baseline (pre-intervention)
and follow-up (3 and 6 months after
intervention delivery)
(b)Calculating variance of the intervention primary
(weight measurements) and secondary
(questionnaire) outcome measures for the
pregnant women at baseline (3rd trimester)
and follow-up (3, 6, 9 and 12 months postnatal)
(c)Rates of recruitment and attrition of midwives
and pregnant women who enrol in the study
at the end of the study period
5. Clinical audit: data required to inform economic
evaluation for a future definitive trial will be
measured by an audit of routine antenatal data
collection of participating women using handheld
and electronic medical records to inform the
variables to be included in the development
of a framework for economic modelling and
variables not routinely recorded which require
further data collection.
6. Maternity electronic patient records of pregnant
women’s characteristics including maternal age,
BMI, ethnic group, parity, employment status
and socio-economic status (determined by
postcode anonymised by data linkage with index
of multiple deprivation data) will be retrieved
from the electronic patient records for all
eligible women in their third trimester during
the recruitment period. Data will be anonymised
and aggregated to compare with recruited women to
determine any participation bias for each site.
Follow-up
Midwives will be followed up for 6 months after de-
livery of the intervention. Pregnant women recruited
to provide post-intervention questionnaire data will
be followed up for 1 year postnatally.
Analysis
All quantitative and qualitative data analyses will be de-
scriptive with the purpose of informing the development
of the definitive trial. Analysis will include recruitment
and retention rates, feasibility and fidelity of intervention
delivery (i.e. have all components of the intervention been
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delivered as planned), any intervention organisation and
delivery requirements, data collection procedures for a
definitive trial, data requirements, timescales required and
procedures for data manipulation for a definitive trial (e.g.
data entry or coding requirements for qualitative and
quantitative data).
Thematic analysis will be used for the qualitative focus
group (midwives) and interview (pregnant women) data.
The analyses will be used to inform the further develop-
ment and refinement of the intervention content, delivery
and data collection methods prior to a definitive trial.
The data analysis of the quantitative outcome measures
will be descriptive (percentages, means and standard
deviations or 5-number summaries [i.e. the minimum,
lower quartile, median, upper quartile and maximum]
as appropriate), with the primary aim of providing
estimates of key trial parameters, including rates of
recruitment, retention, data completion and the variability
of proposed outcome measures. These key trial parame-
ters will be used to inform power calculations for the
definitive trial and to inform decisions about which out-
come measures to use in the definitive trial (e.g. are any
time points for maternal weight status consistently
complete or incomplete, what routine data we can yield
from the clinical audit etc). Estimates required to inform
power calculations for a definitive trial are:
 An estimate of the variability (standard deviation)
for continuous outcome measures
 An estimate of proportions (percentages) for
categorical outcome measures
 An estimate of the intracluster correlation (ICC)
for these measures to inform the power calculation;
though given the imprecision in this estimate due
to the small sample size, other sources of estimates
will also need to be explored (e.g. drawing upon
ICCs reported in similar studies).
Data management, monitoring and adverse events
This is a low-risk pilot trial, and major safety issues
are not anticipated. The project advisory group
(PAG) includes independent members (described in
the Acknowledgements) and will be responsible for
monitoring the conduct of the pilot trial. The full
PAG will have one pre-intervention meeting, one
meeting following intervention delivery and one
meeting annually until the end of the study. Add-
itional monitoring of study conduct and data col-
lected will be performed by a combination of central
review and site monitoring visits (NH) to ensure the
site files are maintained and the study is conducted
in accordance with Good Clinical Practice (GCP).
The study may be subject to inspection and audit by
the sponsor NHS Trust and other regulatory bodies
to ensure adherence to GCP.
The intervention in this pilot study is targeted ex-
clusively at midwives. Therefore, any intervention adverse
events will not involve pregnant women, and adverse
events related to the pregnant women will not be captured
by the study. However, adverse events which would result
in automatic withdrawal of pregnant or postnatal women
(unrelated to the study) will be checked before each data
collection contact. There is low risk of adverse events
relating directly to the intervention (midwifery training).
There is a minimal possibility that midwives may become
upset during the training (e.g. being asked to reflect on
their past practice experiences if there has been a par-
ticularly negative experience). In this circumstance, the
following procedures will be put in place: stop the inter-
vention delivery, ask the midwife if she would like to leave
the room for a while (supported by the observer who will
be present during the intervention delivery), remind the
midwife of her option to withdraw from the intervention,
signpost to follow-up staff support in their local NHS
Trust if necessary (this would involve suggesting that they
contact their allocated supervisor of midwives or line
manager for further support) and any instance of adverse
events will be recorded in the study file at the related site.
All primary data collection will be confidential and
comply with the Data Protection Act (1998), and data
will be anonymised using the midwife and pregnant
women’s unique study ID number. No personal data will
leave the NHS clusters without explicit consent and only
when absolutely necessary (e.g. names and phone num-
bers required for University researchers to arrange in-
terviews with pregnant women). All paper-based study
records will be kept in a locked filing cabinet with
restricted access, and electronic data on a secure net-
work folder, password-protected with restricted access.
Double data entry will be used for all questionnaires to
minimise data entry errors. All data will be subject to
validity checks before analysis (e.g. to identify missing
data, valid data ranges etc).
Discussion
This pilot study has been developed to test the feasibility
and acceptability of delivering and evaluating an imple-
mentation intervention for maternal obesity and weight
management, targeting community midwives’ routine
clinical practice behaviours, using a cluster RCT design.
Community midwives have been specifically selected
due to the majority of the NICE recommendations being
related to the booking appointment (first antenatal
appointment with a health professional) [16], and it is
usually the role of the community midwife to carry out
this consultation. Community midwives also have a key
public health role as they usually have the most contacts
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with women throughout the antenatal period. However,
some NHS Trusts also have hospital-based midwives with
a specific maternal obesity or weight management role
(e.g. specialist public health midwives, midwives working
within antenatal obesity clinics etc), and therefore, these
selected midwives have also been included. We acknow-
ledge that other health professionals are also likely to need
support to provide evidence-based obesity and weight
management support for pregnant women, such as other
midwife specialities, obstetricians, health visitors, GPs,
maternity and health care assistants and student health
professionals. Some of these specialties report similar
barriers to practice to midwives in the evidence base
which has been used to inform the development of the
GLOWING intervention [19], and therefore, the inter-
vention may be transferrable to other disciplines. How-
ever, further exploration of the feasibility of delivering the
GLOWING intervention to additional disciplines would
be required.
A cluster design is the gold standard in implementa-
tion research due to the significant risk of contamination
between control and intervention groups when rando-
mising at individual level [55]. In this pilot trial, there is
risk of contamination if either midwives or pregnant
women are randomised at the individual level. Rando-
mising pregnant women within the NHS Trusts to
receive advice and support relating to obesity and weight
management would not be feasible as it would require
the midwives to ‘switch on’ their behaviours for those
women randomised to the intervention arm and to
‘unlearn’ their behaviours for women randomised to the
control arm. Randomising individual midwives to in-
tervention and control arms would also be unfeasible.
Community midwives within NHS Trusts usually work
in locality-based teams out in the local community,
sometimes within the same GP practices, and interact
on a daily basis. The risk of contamination between those
working closely together would be high using individual
randomisation of midwives, especially relating to the
control midwives’ access to the training materials and the
women’s resources in routine practice. Community
midwife teams also share care of pregnant women, and
any one pregnant woman could potentially see a different
community midwife from the same team at each antenatal
visit and occasionally from other teams within the NHS
Trust. Therefore, there could also be contamination of
control midwives accessing the women’s resources during
routine care.
The shared care between midwives is also the reason
for aiming to recruit all eligible midwives to participate
in the intervention sessions, even though the target
sample size for data collection is only 30 midwives per
arm. If all midwives participate in GLOWING, it should
increase consistency of advice and support for women.
Data will be collected from pregnant and postnatal
women about their midwives’ provision of advice and
support around obesity and weight management, and
this would also require all midwives to participate in the
intervention to guarantee that the women are reporting
the behaviours of GLOWING intervention midwives.
The intervention targets maternal obesity, although we
acknowledge that women with a booking BMI < 30 kg/m2
are also likely to benefit from weight management
support from community midwives. The NICE guideline
recommendations on healthy diet and physical activity
behaviours and managing weight in pregnancy are relevant
to women with a BMI ≥ 18.5 kg/m2 (including those with a
recommended BMI, overweight and obese), although the
guidelines specify that they are particularly relevant to
women with a BMI ≥ 30 kg/m2 [16]. Midwives can apply
the changes in practice to women with a BMI < 30 kg/m2,
but the intervention is only providing the women’s resource
packs to the highest risk population of women with obesity.
The data collection and analysis during the pilot trial
will determine if it is feasible and acceptable to deliver
GLOWING as planned to all eligible midwives in the
intervention arm. The results of the GLOWING pilot
trial will be used to further develop and refine GLOWING
where necessary prior to a definitive trial to evaluate the
effectiveness and cost-effectiveness of the intervention.
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